Last reviewed · How we verify

NCT03452696: CALCIMIP

Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate

Completed Phase 3 Last updated 8 April 2019
What this trial tests

Phase 3 trial testing Calcium supplement in Hypocalcemia; Dietary in 208 participants. Completed in 3 April 2019.

Timeline
15 June 2018
Primary endpoint
28 March 2019
3 April 2019

Quick facts

Lead sponsorInstituto Palacios
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment208
Start date15 June 2018
Primary completion28 March 2019
Estimated completion3 April 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Palacios — full company profile →

Who can join

Adults 45 to 70, female only, with Hypocalcemia; Dietary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventional Clinical trial with food supplement, randomized, double-blind, comparative between microencapsulated calcium, calcium carbonate salts standardized and calcium citrate, in a population of postmenopausal women, lasting 1 month.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical study of the tolerability of calcium carbonate-casein microcapsules as a dietary supplement in a group of postmenopausal women.
    Palacios S, Ramirez M, Lilue M. · · 2020 · cited 4× · PMID 32362931 · DOI 10.7573/dic.2020-1-4

Verify or expand the search:

Other trials of Calcium supplement

Trials testing the same drug.

Other Instituto Palacios trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03452696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing